Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
40 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Pfenex Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Pfenex Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Pfenex Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Pfenex Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Pfenex Inc.'s pipeline products Reasons to buy - Evaluate Pfenex Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Pfenex Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Pfenex Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Pfenex Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pfenex Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Pfenex Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Pfenex Inc. Snapshot 5 Pfenex Inc. Overview 5 Key Information 5 Key Facts 5 Pfenex Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Pfenex Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pfenex Inc. - Pipeline Products Glance 13 Pfenex Inc. - Clinical Stage Pipeline Products 13 Phase I Products/Combination Treatment Modalities 13 Pfenex Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Pfenex Inc. - Drug Profiles 16 ranibizumab biosimilar 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 certolizumab pegol biosimilar 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 filgrastim 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 interferon beta-1b 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 parathyroid hormone biosimilar 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 pegaspargase biosimilar 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 pegfilgrastim 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 peginterferon alfa-2a 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 peginterferon alfa-2b 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Px-533 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Px-563L 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 somatropin biosimilar 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Second Generation Px-563L 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Pfenex Inc. - Pipeline Analysis 30 Pfenex Inc. - Pipeline Products by Target 30 Pfenex Inc. - Pipeline Products by Route of Administration 32 Pfenex Inc. - Pipeline Products by Molecule Type 33 Pfenex Inc. - Pipeline Products by Mechanism of Action 34 Pfenex Inc. - Recent Pipeline Updates 35 Pfenex Inc. - Dormant Projects 37 Pfenex Inc. - Locations And Subsidiaries 38 Head Office 38 Appendix 39 Methodology 39 Coverage 39 Secondary Research 39 Primary Research 39 Expert Panel Validation 39 Contact Us 40 Disclaimer 40
List of Tables Pfenex Inc., Key Information 5 Pfenex Inc., Key Facts 5 Pfenex Inc. - Pipeline by Indication, 2014 8 Pfenex Inc. - Pipeline by Stage of Development, 2014 9 Pfenex Inc. - Monotherapy Products in Pipeline, 2014 10 Pfenex Inc. - Partnered Products in Pipeline, 2014 11 Pfenex Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 Pfenex Inc. - Phase I, 2014 13 Pfenex Inc. - Preclinical, 2014 14 Pfenex Inc. - Discovery, 2014 15 Pfenex Inc. - Pipeline by Target, 2014 31 Pfenex Inc. - Pipeline by Route of Administration, 2014 32 Pfenex Inc. - Pipeline by Molecule Type, 2014 33 Pfenex Inc. - Pipeline Products by Mechanism of Action, 2014 34 Pfenex Inc. - Recent Pipeline Updates, 2014 35 Pfenex Inc. - Dormant Developmental Projects,2014 37
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.